IMR Press / FBE / Volume 15 / Issue 1 / DOI: 10.31083/j.fbe1401002R
Cite this article
10
Downloads
99
Views
  • Academic Editor
    Baohong Zhang
Chapters
Reference
References
Open Access Retraction
Retraction: Blanca Alegría, Carlos Alfaro. Clinical grade adjuvants to mature CD141+ DCs for immunotherapy. Frontiers in Bioscience (Elite Edition). 2022; 14: 2.
Show Less
1 Clínica Universitaria de Navarra, Universidad de Navarra, Av. Pio XII 36, 31008 Pamplona, Spain
2 Centre for Applied Medical Research, Universidad de Navarra, Av. Pio XII 55, 31008 Pamplona, Spain
3 IMR Press, 112 Robinson Road, #03-01, Robinson 112, 068902 Singapore
*Correspondence: calfale@unav.es (Carlos Alfaro); FBE@imrpress.com (FBE Editorial Office)
Front. Biosci. (Elite Ed) 2023, 15(1), 4; https://doi.org/10.31083/j.fbe1401002R
Submitted: 29 September 2022 | Published: 2 February 2023
Copyright: © 2023 The Author(s). Published by IMR Press.
This is an open access article under the CC BY 4.0 license.

The Frontiers in Bioscience-Elite Editorial Office has retracted the paper mentioned above [1]. The reasons given are that: (1) The ethical approval is fake. (2) Most of the paper was not written by the authors, but was copied from a manuscript in preparation without permission. (3) The experiments were not conducted by the authors, and the data was obtained by other researchers. (4) The funding information is wrong. (5) The authors are not affiliated to the reported university.

The Editor-in-Chief and Editorial Office of the Frontiers in Bioscience-Elite have checked the case, and approved the retraction. IMR Press has been following the regulations of the Committee on Publication Ethics (COPE) and takes very seriously the responsibility to enforce strict ethical policies and standards.

References
[1]
Alegría B, Alfaro C. Clinical grade adjuvants to mature CD141+ DCs for immunotherapy. Frontiers in Bioscience (Elite Edition). 2022; 14: 2.

Publisher’s Note: IMR Press stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share
Back to top